Tag: pharmaceuticals

Blog Posts (30)

May 14, 2012

AJOB: An Independent Journal

It has been implied by Carl Elliott and William Heisel that it has ever been claimed that “financial links between the Center for Practical Bioethics, AJOB and Purdue Pharma” exist and that “what reporters may find is that the center is tied up” with AJOB.  …

October 4, 2011

A Duty to Report Dead Ends?

When an investigational agent is being studied by pharma, is there an ethical responsibility to disclose the findings of that research, even if the agent is no longer being studied or being brought to market?…

August 11, 2011

Drug Shortages Hurt Man....and His Best Friend

When a reproductive oncologist in our clinical ethics certificate program did a presentation on drug shortages in oncology last month, I thought perhaps this was just a highly specialized problem.…

September 13, 2010

Guinea-Pigging: It's Not A Real Word, But It's A Real-World Phenomenon

Watch to see the story of “The Life of a Professional Guinea Pig” courtesy of TIME.

Spencer, or as I would describe him a walking human pin cushion (shown below), tells his story of being a healthy volunteer for Phase I research.…

January 25, 2010

"Extraordinary Messiness"

Hollywood has taken up orphan diseases before–remember “Lorenzo’s Oil”? And bioethics movies generally have been increasingly common, even just in the last year.…

November 2, 2009

Q & A on What is a Blockbuster Anti-Wrinkle Cream Worth, Morally Speaking Or How Many Fetuses Does It Take To Make a Great Cosmeceutical

Question: What is it worth to produce a blockbuster anti-wrinkle cream?
Hypothetical Answer from Cosmeceutical Company: A single skin biopsy of a 14-week old voluntarily aborted fetus from a minor with consent from her parents.…

July 21, 2009

Keeping Your Skin Youthful, The Stem Cell Way

Stem cells are, apparently, all the rage in the world of cosmetics. Slather them on your face to keep your face young and ageless or to simply make yourself more beautiful on your eyes, cheeks, or lips.…

May 18, 2009

Lose Your Job, Keep Your Drugs

According to Judith Graham at the Chicago Tribune’s Triage blog, Pfizer has created a new program to allow the unemployed–and thus uninsured–to keep access to their prescription drugs for one year.…

May 1, 2009

Merck Makes Phony Peer-Review Journal

It’s a safe guess that somewhere at Merck today someone is going through the meeting minutes of the day that the hair-brained scheme for the Australasian Journal of Bone and Joint Medicine was launched, and that everyone who was in the room is now going to be fired.…

January 14, 2009

Direct-to-Consumer Ads Fail to Direct Many Consumers

According to MSNBC, direct-to-consumer advertising for pharmaceuticals are cluttering the airwaves with offers to cure Americans of their bipolar disorder, irritable bowel disease, sleeplessness, acid reflux, high cholesterol and more.…

View More Blog Entries

Published Articles (2)

American Journal of Bioethics: Volume 14 Issue 3 - Mar 2014

The Ethics of Advertising for Health Care Services Yael Schenker, Robert M. Arnold & Alex John London

American Journal of Bioethics: Volume 11 Issue 6 - Jun 2011

It's Time for Bioethics to See Chronic Pain as an Ethical Issue

News (32)

February 17, 2017 9:00 am

An old drug gets a new price to fight a rare disease: $89,000 a year (Washington Post)

An old steroid treatment, long available outside the United States, received approval this week for a rare disease that afflicts about 15,000 Americans. Though not previously approved in the United States, the drug, deflazacort, has for years been available to patients suffering from the devastating and fatal disease Duchenne muscular dystrophy; families can import it from abroad for about $1,200 per year on average. The new list price for the drug? $89,000 a year.

January 31, 2017 9:00 am

Vaccine initiative marks bold resolution (Science)

Clearly, private companies cannot be expected to invest on their own. But it is incumbent on governments to invest, and thus address this market failure, in partnership with pharma. It is therefore encouraging that there is now a solid plan to do just that: the Coalition for Epidemic Preparedness Innovations (CEPI), launched on 18 January at the World Economic Forum in Davos, Switzerland, aims to develop and take through early clinical trials vaccines against potential threats. It already has enough cash to work on three — MERS, Nipah-virus infection and Lassa fever.

December 20, 2016 9:00 am

OxyContin goes global — “We’re only just getting started” (LA Times)

Former U.S. Food and Drug Administration commissioner David A. Kessler has called the failure to recognize the dangers of painkillers one of the biggest mistakes in modern medicine.

November 3, 2016 8:00 am

More Children Are Being Poisoned By Prescription Opioids (NPR)

Young children and teenagers are increasingly likely to be poisoned by opioid painkillers that are often prescribed for other family members, a study finds.

October 28, 2016 8:00 am

Big pharma is gearing up to defend drug prices (Washington Post)

The skyrocketing costs of prescription drugs has been noticeably absent from discussion in the presidential debates — even as bipartisan anger about price gouging has united Congress. But the trade group for the pharmaceutical industry, PhRMA, is gearing up to defend drug prices after the election, seeking an additional $100 million in annual dues from its members, according to a report from Politico.

October 27, 2016 8:00 am

How drugs intended for patients ended up in the hands of illegal users: ‘No one was doing their job’ (Washington Post)

For 10 years, the government waged a behind-the-scenes war against pharmaceutical companies that hardly anyone knows: wholesale distributors of prescription narcotics that ship drugs from manufacturers to consumers.

October 19, 2016 8:00 am

The drug industry’s answer to opioid addiction: More pills (Washington Post)

Cancer patients taking high doses of opioid painkillers are often afflicted by a new discomfort: constipation. Researcher Jonathan Moss thought he could help, but no drug company was interested in his ideas for relieving suffering among the dying.

October 13, 2016 8:00 am

Major Investor Sues Theranos (WSJ)

One of Theranos Inc.’s biggest financial backers has sued the embattled startup and its founder for allegedly lying to attract its nearly $100 million investment, according to a fund document and people familiar with the matter.

October 3, 2016 8:00 am

Furor Over Drug Prices Puts Patient Advocacy Groups in Bind (NY Times)

Public anger over the cost of drugs has burned hot for a year, coursing through social media, popping up on the presidential campaign, and erupting in a series of congressional hearings, including one last week over the rising price of the allergy treatment EpiPen.

August 19, 2016 8:00 am

Scientists Engineer An Opioid That May Reduce Pain With Less Risk (NPR)

Once people realized that opioid drugs could cause addiction and deadly overdoses, they tried to use newer forms of opioids to treat the addiction to its parent. Morphine, about 10 times the strength of opium, was used to curb opium cravings in the early 19th century. Codeine, too, was touted as a nonaddictive drug for pain relief, as was heroin.

 

View More News Items